RT Journal Article
SR Electronic
T1 Detailed Analysis of Surface Infection Barrier on Hands: Relationship with Morbidity to Infection Diseases and Identification of Antimicrobial Components
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.12.09.20246306
DO 10.1101/2020.12.09.20246306
A1 Nishioka, Yuki
A1 Nagano, Kenichi
A1 Koga, Yoshitaka
A1 Okada, Yasuhiro
A1 Mori, Ichiro
A1 Hayase, Atsuko
A1 Mori, Takuya
A1 Manabe, Kenji
YR 2020
UL http://medrxiv.org/content/early/2020/12/11/2020.12.09.20246306.abstract
AB Although the surface of hands in humans is known to harbor high levels of antimicrobial activity, reports investigating the relationship between antimicrobial activity and morbidity in infectious diseases are lacking. Additionally, the precise components involved in this activity are not known. Therefore, in this study, a method was developed to quantitatively measure the antimicrobial activity of the components found on the surface of hands, which was then compared with the medical history of the participants for infectious diseases. As a result, the antimicrobial activity of the surface of the hands was found to be positively associated with the history of infection in individuals. Furthermore, a comprehensive analysis of the components on the surface of hands indicated that organic acids and antimicrobial peptides are highly correlated with antimicrobial activity. The high amounts of lactic acid found on the surface of hands suggested it is an important factor in the hand surface infection barrier. Here we showed that the application of lactic acid within the range of the amounts present on the hand surface was found to significantly improve the antimicrobial activity of the hands. Taken together, these results demonstrate that this new method can be used to quantify antimicrobial activity, which opens new avenues for the development of hand hygiene practices by enhancing the antimicrobial activity on the surface of hands using natural ingredients against pathogens.Competing Interest StatementAll authors are employees of the study sponsor, Kao Corporation, Tokyo, JapanFunding StatementThis study was funded by Kao Corporation, Tokyo, Japan. The Kao Corporation played a role in the design of the study, the collection, analysis, and interpretation of data, and the writing of the manuscript.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study protocol, including sample collection, was reviewed, and approved by the Ethical Committee of the Kao Corporation. (1) and (4) were approved as S311-200807, (2) was approved as T116-18032, and (3) was approved as S108-171024. Informed written consent was obtained from all research participants after the procedures had been explained with documentation. All experiments were conducted according to the principles of the Declaration of Helsinki.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.